Prostate Cancer - Results from #19000

Comparison of ultrasound-guided transrectal and transperineal prostate biopsies in clinical application - Abstract March 10, 2015

Exploiting synergy: Immune-based combinations in the treatment of prostate cancer - Abstract March 9, 2015

Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms - Abstract March 9, 2015

Nutrition, dietary interventions and prostate cancer: The latest evidence - Abstract March 9, 2015

Outcomes and predictors of T3a prostate cancer treated by permanent interstitial brachytherapy combined with external radiotherapy and hormone therapy - Abstract March 9, 2015

Metformin does not predict for prostate cancer diagnosis, grade, or volume of disease after transperineal template-guided mapping biopsy - Abstract March 9, 2015

Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy - Abstract March 9, 2015

Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with 18F-fluorocholine positron emission tomography/computed tomography - Abstract March 9, 2015

Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer - Abstract March 9, 2015

MR imaging-guided prostate biopsy: Technical features and preliminary results - Abstract March 9, 2015

Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer - Abstract March 9, 2015

Value of bimodal 18F-choline-PET/MRI and trimodal 18F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy - Abstract March 9, 2015

Radiation therapy for clinically localized prostate cancer: Long-term results of 469 patients from a single institution in the era of dose escalation - Abstract March 9, 2015

Prostate cancer in 2014 - 2015: Advances and ongoing challenges in therapeutics, biomarkers, and precision medicine March 9, 2015

#GU15 - Novel imaging modalities boost detection of early metastatic disease in prostate cancer - Session Highlights March 9, 2015

Final report of the Intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer - Abstract March 7, 2015

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results - Abstract March 7, 2015

Technological aspects of delivering cryotherapy for prostate cancer - Abstract March 6, 2015

Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS) - Abstract March 6, 2015

Is further screening of men with baseline PSA less than 1 ng ml-1 worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau) - Abstract March 6, 2015

Page 951 of 1457